AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $428,000 | +262.7% | 28,234 | +79.7% | 0.00% | – |
| Q2 2022 | $118,000 | +12.4% | 15,715 | +36.5% | 0.00% | – |
| Q1 2022 | $105,000 | +11.7% | 11,512 | -14.1% | 0.00% | – |
| Q4 2021 | $94,000 | -71.7% | 13,404 | -53.9% | 0.00% | – |
| Q3 2021 | $332,000 | -29.2% | 29,104 | -0.7% | 0.00% | – |
| Q2 2021 | $469,000 | -6.4% | 29,305 | +4.5% | 0.00% | – |
| Q1 2021 | $501,000 | +32.5% | 28,053 | +0.2% | 0.00% | – |
| Q4 2020 | $378,000 | +35.0% | 28,001 | +17.6% | 0.00% | – |
| Q3 2020 | $280,000 | -36.5% | 23,811 | -20.2% | 0.00% | – |
| Q2 2020 | $441,000 | +21.5% | 29,852 | +11.1% | 0.00% | – |
| Q1 2020 | $363,000 | -95.7% | 26,864 | -92.4% | 0.00% | -100.0% |
| Q4 2019 | $8,492,000 | +22.3% | 351,353 | -2.7% | 0.00% | 0.0% |
| Q3 2019 | $6,942,000 | -35.6% | 361,167 | -1.1% | 0.00% | -50.0% |
| Q2 2019 | $10,787,000 | -37.8% | 365,043 | +0.0% | 0.00% | -33.3% |
| Q1 2019 | $17,338,000 | +30.8% | 365,018 | -0.6% | 0.00% | +50.0% |
| Q4 2018 | $13,254,000 | -41.2% | 367,140 | +0.2% | 0.00% | -33.3% |
| Q3 2018 | $22,547,000 | -7.4% | 366,320 | +1.7% | 0.00% | -25.0% |
| Q2 2018 | $24,341,000 | +31.3% | 360,346 | +5.5% | 0.00% | +33.3% |
| Q1 2018 | $18,533,000 | -5.3% | 341,619 | +4.3% | 0.00% | 0.0% |
| Q4 2017 | $19,578,000 | +47.4% | 327,671 | +19.9% | 0.00% | +50.0% |
| Q3 2017 | $13,286,000 | +9.3% | 273,373 | +18.1% | 0.00% | 0.0% |
| Q2 2017 | $12,160,000 | -38.9% | 231,402 | -47.3% | 0.00% | -50.0% |
| Q1 2017 | $19,908,000 | +1873.0% | 438,979 | +1546.0% | 0.00% | – |
| Q4 2016 | $1,009,000 | +0.3% | 26,670 | +0.0% | 0.00% | – |
| Q3 2016 | $1,006,000 | -90.3% | 26,660 | -94.7% | 0.00% | -100.0% |
| Q3 2014 | $10,391,000 | – | 502,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |